- Lobbying
- Lobbying by National Association of Chain Drug Stores
Lobbying Relationship
Bills mentioned
H.R.1024: Medication Therapy Management Empowerment Act of 2013
Sponsor: Cathy McMorris Rodgers (R-Wash.)
S.2862: Regulatory Transparency, Patient Access, and Effective Drug Enforcement...
Sponsor: Orrin G. Hatch (R-Utah)
H.R.4709: Ensuring Patient Access and Effective Drug Enforcement Act of 2014
Sponsor: Tom Marino (R-Pa.)
H.R.4190: To amend title XVIII of the Social Security Act to provide for coverage...
Sponsor: Brett Guthrie (R-Ky.)
H.R.1971: Pharmacy Competition and Consumer Choice Act of 2011
Sponsor: Cathy McMorris Rodgers (R-Wash.)
S.1058: Pharmacy Competition and Consumer Choice Act of 2011
Sponsor: Mark Pryor (D-Ark.)
H.R.4215: Medicare Pharmacy Transparency and Fair Auditing Act
Sponsor: Cathy McMorris Rodgers (R-Wash.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Jack Fields | Former Member of Congress |
Allen Boyd | Former Member of Congress |
Jocelyn Hong | Cong. Aide, Sen. Glenn & Cong. Eckart |
Jay Grimes | Staff, Cmt on Armed Services |
Hadley Berryhill | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
U.S. House of Representatives
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate